VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 70 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,616,359 | -69.9% | 208,562 | -55.6% | 0.00% | -70.0% |
| Q2 2023 | $5,373,221 | +940.2% | 469,277 | +600.4% | 0.01% | +900.0% |
| Q1 2023 | $516,547 | -54.0% | 66,997 | -64.7% | 0.00% | -50.0% |
| Q3 2022 | $1,123,000 | -51.8% | 189,736 | -37.9% | 0.00% | -50.0% |
| Q1 2022 | $2,328,000 | +94.8% | 305,445 | -30.9% | 0.00% | +100.0% |
| Q4 2021 | $1,195,000 | +1227.8% | 441,881 | +1922.2% | 0.00% | – |
| Q2 2021 | $90,000 | -41.6% | 21,852 | -33.2% | 0.00% | -100.0% |
| Q1 2021 | $154,000 | -87.3% | 32,695 | -65.9% | 0.00% | -87.5% |
| Q2 2020 | $1,211,000 | -31.9% | 95,954 | -50.7% | 0.01% | -55.6% |
| Q1 2020 | $1,779,000 | +145.4% | 194,444 | +361.4% | 0.02% | +200.0% |
| Q3 2019 | $725,000 | -67.4% | 42,141 | -64.1% | 0.01% | -33.3% |
| Q3 2018 | $2,224,000 | – | 117,498 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |